Medical News

RSS

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Sigma-Tau Pharmaceuticals, Inc. announced today that the Company was recognized last evening as a rare disease pioneer at the 30th anniversary celebration of The National Organization for Rare Disorders.

15 May 2013

Experts to discuss new studies about hypertension at ASH meeting in San Francisco

Considered the "silent killer," high blood pressure affects approximately one billion people worldwide, including one in three adults in the United States. From May 15 – 18, 2013, members of the medical community from across the globe gather at the 28th Annual Scientific Meeting of the American Society of Hypertension in San Francisco to discuss the epidemic.

15 May 2013

Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE (Conformité Européenne) Mark approval for its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System.

15 May 2013

ALK, AAFA partner to create unique online resource for people living with allergies

In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.

15 May 2013

Tokai Pharmaceuticals raises $35.5M in Series E financing

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that the company raised $35.5 million in a Series E financing based on encouraging clinical progress and investor support for galeterone (TOK-001), Tokai's lead prostate cancer drug candidate.

15 May 2013

Primex Wireless releases latest SNS Applications Management Platform software

Primex Wireless – the leading provider of solutions to automate and maintain facility compliance, increase efficiencies and reduce risk for enterprise organizations – announced the release of its latest SNS Applications Management Platform (AMP 4.0) software, incorporating support for the company's new SNS Differential Pressure Monitoring solution.

15 May 2013

MCA presents 2013 John Allenburg Meritorious Award to Dr. Mark Dehen

The Minnesota Chiropractic Association presented Dr. Mark Dehen, with the "2013 John Allenburg Meritorious Award" during the Annual Chiropractic Celebration and Convention recently held at the Marriott Mall of America.

15 May 2013

First Edition: May 15, 2013

Today's headlines include reports about how the latest Congressional Budget Office projections could further stall efforts to reach a grand bargain that includes changes to Medicare and other entitlement programs.

15 May 2013

Increasing body fat after middle age makes arteries stiffer, new study reveals

Having too much body fat makes arteries become stiff after middle age, a new study has revealed.

15 May 2013

Microclinic International to promote healthier living in the Cumberland Valley Region

Microclinic International was awarded a major CDC grant to promote healthier living and combat chronic disease in the Cumberland Valley Region in Appalachian Kentucky.

15 May 2013

Sterling Insurance increases availability of Sterling Critical Condition to 31 states

Sterling Insurance is proud to announce the expansion of Sterling Critical Condition in 18 additional states, increasing the availability to 31 states.

15 May 2013

Southern Denmark to use IBM's Shared Care Platform to improve care for patients with chronic illness

IBM announced today that the Region of Southern Denmark is launching a new program to provide comprehensive insight to improve the quality and comprehensiveness of care for patients with chronic illness.

15 May 2013

RaySearch Laboratories gets FDA approval for RayStation 3.5

In March RaySearch Laboratories AB announced that version 3.5 of RaySearch's RayStation treatment planning system had been released for clinical use.

15 May 2013

Search, Share, Spare campaign to raise awareness about breast cancer surgery options

Studies have shown nearly 70 percent of patients with breast cancer do not discuss all surgical options with their surgeon before their initial surgery and that such a discussion significantly affects a woman's treatment decision.

15 May 2013

Exercise is good for us - no matter what our age

The red double-decker buses that are symbolic of the city of London have an altogether different significance if you study heart disease. Sixty years ago, these iconic buses helped a Scottish medical doctor named Jerry Morris discover the link between physical activity and heart attacks.

15 May 2013

Echevarne to distribute Natera's non-invasive prenatal screening test in Spain

Natera, a leading innovator in prenatal genetic testing, and Echevarne, a leading clinical analysis laboratory in Spain, today announced the signing of a distribution agreement for Echevarne to offer Natera's non-invasive prenatal screening test, Panorama, through its facilities in Spain.

From Natera 15 May 2013

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.

15 May 2013

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other week, have enrolled their first patients.

15 May 2013

A growing number of patients learn of allergies only after surgery is done

Imagine what Paula Spurlock must have been going through. Shortly after having a hip replaced in 2011, the trouble started. "I had horrible itching, really bad migraines and intense pain throughout my body," she said. "I couldn't take it. Every single thing in me itched."

15 May 2013

Many physicians reject Medicaid -- A cause for concern as the expansion approaches

McClatchy reports that projections highlight how the shortage of physicians in general as well as those who choose not to accept Medicaid patients could undermine the health law's intent. Also in the news, fits and starts surround this health law provision in Pennsylvania, Arizona, Texas, Louisiana, Ohio and Colorado.

15 May 2013

Medical News

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Experts to discuss new studies about hypertension at ASH meeting in San Francisco

Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System receives CE Mark approval

ALK, AAFA partner to create unique online resource for people living with allergies

Tokai Pharmaceuticals raises $35.5M in Series E financing

Primex Wireless releases latest SNS Applications Management Platform software

MCA presents 2013 John Allenburg Meritorious Award to Dr. Mark Dehen

First Edition: May 15, 2013

Increasing body fat after middle age makes arteries stiffer, new study reveals

Microclinic International to promote healthier living in the Cumberland Valley Region

Sterling Insurance increases availability of Sterling Critical Condition to 31 states

Southern Denmark to use IBM's Shared Care Platform to improve care for patients with chronic illness

RaySearch Laboratories gets FDA approval for RayStation 3.5

Search, Share, Spare campaign to raise awareness about breast cancer surgery options

Exercise is good for us - no matter what our age

Echevarne to distribute Natera's non-invasive prenatal screening test in Spain

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

A growing number of patients learn of allergies only after surgery is done

Many physicians reject Medicaid -- A cause for concern as the expansion approaches

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News